PL74569B2 - - Google Patents

Download PDF

Info

Publication number
PL74569B2
PL74569B2 PL15270571A PL15270571A PL74569B2 PL 74569 B2 PL74569 B2 PL 74569B2 PL 15270571 A PL15270571 A PL 15270571A PL 15270571 A PL15270571 A PL 15270571A PL 74569 B2 PL74569 B2 PL 74569B2
Authority
PL
Poland
Prior art keywords
acid
cyclohexyl
allyl
solution
potassium dichromate
Prior art date
Application number
PL15270571A
Other languages
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to PL15270571A priority Critical patent/PL74569B2/pl
Publication of PL74569B2 publication Critical patent/PL74569B2/pl

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Pierwszenstwo: 30.12.1971 (P. 152705) Zgloszenie ogloszono: 30.05.1973 Opis patentowy opublikowano: 28.04.1975 74569 KI. 12p,7/01 MKP C07d 51/20 CZYTELNIA Urzedu Patentowego Twórcy wynalazku: Boguslaw Bobranski, Halina Matczak Uprawniony z patentu tymczasowego: Akademia Medyczna Instytut Che¬ mii i Technologii Srodków Leczni¬ czych Zaklad Chemii Farmaceu¬ tycznej, Wroclaw (Polska) Sposób otrzymywania kwasu l-cykloheksylo-5-allilo-5-acetonylobarbiturowego Wynalazek dotyczy sposobu otrzymywania kwasu l-cykloheksylo-5-allilo-5-acetonyldba!rbiturowego, bedacego materialem wyjsciowym do wytwarzania srodków o silnym dzialaniu przeciwzapalnym, ta¬ kich jak niektóre pochodne kwasu 1-cykloheksylo- barhituirowego zawienajace w polozeniu 5 oprócz grupy allilowej inne grupy funkcyjne.Kwas l-cykloheksylo-5-allilo-5-acetonylobarbitu- rowy jest zwiazkiem nowym, dotychczas nie opisa¬ nym. Zgodnie ze sposobem wedlug wynalazku moz¬ na go otrzymac z kwasu l-cykloheksylo-5-allilo-5- -ip-hydroksypropylobarbiturowego w wyniku utle¬ nienia roztworu dwuchromianu potasu w srodowis¬ ku kwasnym w temperaturze 60—90°C.Po krystalizacji z rozcienczonego alkoholu etylo¬ wego wykazuje on temperature topnienia 126°C.Przyklad: Ig kwasu l-cykloheksylo-5-allilo- -5-p-hydroksypropylobarbiturowego rozciera sie w 10 15 100 ml rozcienczonego kwasu siarkowego w tempe¬ raturze okolo 60°C, a nastepnie wkrapla sie roztwór 0,5 g K.jCr.jOr w 15 ml wody.Po wprowadzeniu calej ilosci dwuchromianu po¬ tasu roztwór ogrzewa sie jeszcze przez 30 min. w temperaturze 95°C. Po oziebieniu odsacza sie su¬ rowy produkt, który krystalizuje sie z rozcienczo¬ nego alkoholu etylowego. Wydajnosc zwiazku o tem¬ peraturze topnienia 126° wynosi 73%. PL PLPriority: December 30, 1971 (P. 152705) Application announced: May 30, 1973 Patent description was published: April 28, 1975 74569 KI. 12p, 7/01 MKP C07d 51/20 READING ROOM of the Patent Office Inventors: Boguslaw Bobranski, Halina Matczak Authorized by a temporary patent: Medical Academy Institute of Chemistry and Technology of Medicinal Agents, Pharmaceutical Chemicals, Wroclaw (Poland) 1-cyclohexyl-5-allyl-5-acetonylbarbituric acid. The invention relates to a method for the preparation of 1-cyclohexyl-5-allyl-5-acetonyldba rbituric acid, which is a starting material for the production of agents with a strong anti-inflammatory action, such as some derivatives of the acid 1 -cyclohexyl-barhitiric acid having other functional groups besides the allyl group in their position. 1-cyclohexyl-5-allyl-5-acetonylbarbitic acid is a novel compound, hitherto not described. According to the process of the invention, it can be obtained from 1-cyclohexyl-5-allyl-5-β-hydroxypropylbarbituric acid by oxidation of a solution of potassium dichromate in an acid medium at a temperature of 60-90 ° C. After crystallization from of diluted ethyl alcohol has a melting point of 126 ° C. Example: 1g of 1-cyclohexyl-5-allyl--5-p-hydroxypropylbarbituric acid is triturated in 10,100 ml of dilute sulfuric acid at a temperature of about 60 ° C, then a solution of 0.5 g of K.jCr.jOr in 15 ml of water is added dropwise. After the total amount of potassium dichromate has been added, the solution is heated for another 30 minutes. at 95 ° C. After cooling, the crude product is filtered off, which crystallizes from dilute ethyl alcohol. The yield of the compound with a melting point of 126 ° is 73%. PL PL

Claims (1)

1. Zastrzezenie patentowe Sposób otrzymywania kwasu l-cykloheksylo-5- -allilo-5-acetonylobarbiturowego, znamienny tym, ze kwas l-cykloheksylo-5-allilo-5-|3-hydroksypropy- lobarbiturowy poddaje sie utlenieniu dwuchromia¬ nem potasowym w roztworze kwasnym w tempe¬ raturze 60—100°C. 74569 PL PL1. Patent claim A method of obtaining 1-cyclohexyl-5-allyl-5-acetonylbarbituric acid, characterized in that 1-cyclohexyl-5-allyl-5- [3-hydroxypropyl barbituric acid is oxidized with potassium dichromate in solution acid at 60-100 ° C. 74569 PL PL
PL15270571A 1971-12-30 1971-12-30 PL74569B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL15270571A PL74569B2 (en) 1971-12-30 1971-12-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL15270571A PL74569B2 (en) 1971-12-30 1971-12-30

Publications (1)

Publication Number Publication Date
PL74569B2 true PL74569B2 (en) 1974-10-31

Family

ID=19956972

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15270571A PL74569B2 (en) 1971-12-30 1971-12-30

Country Status (1)

Country Link
PL (1) PL74569B2 (en)

Similar Documents

Publication Publication Date Title
EP0185259A2 (en) Pteridines, process for their preparation, and their use as intermediates or as medicaments
EP1173176B1 (en) Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity
PL74569B2 (en)
Rapport et al. The Synthesis of Potential Antimalarials. 2-Phenyl-α-(2-piperidyl)-4-quinolinemethanols1, 2
US2203121A (en) Preparation of diacetyldihydromorphinone
Gibson VII.—Nitro-derivatives of o-cresol
US2672463A (en) S-carboxyethyl-thioisosemicarbazones
US2727041A (en) Isonicotinyl hydrazone of m-formyl-benzene sulfonic acid
US2518922A (en) Salicylic acid derivatives and method for making same
US699422A (en) Methylene citric acid and process of making same.
JPS5946244A (en) Hydroxamic acid derivative and its preparation
US2691039A (en) Stilbene-alpha-ketol compounds and process for making the same
US2476925A (en) Preparation of therapeutic substances
US706356A (en) Acet salicyl phenetidin and process of making same.
SU455108A1 (en) Method for producing 1,3,4-thiadiazole derivatives
US2145800A (en) Cinchona sulphanilamide and process of making it
US3073838A (en) Derivatives of hydkogenateb pyridones
US2449908A (en) Preparation op j-amino-x-methyi
US802835A (en) Double salt of ferric chlorid and cotarnin hydrochlorate and process of making same.
US2380478A (en) Lactones of 2-alkyl-3-alkoxy-4-hydroxymethyl-5-carboxypyridine
US1931123A (en) Method of isolating alpha-aryl-beta-aminoethanols and compound so obtained
US2480367A (en) Manufacture of therapeutic substances
US2194179A (en) Thiazole compound and method of making it
US2599509A (en) 5-nitro-2-furfurylidene acetone semicarbazone
US1338297A (en) Trimethyl-acetyl-salicylic-acid compounds